Cargando…

COVID y rellenos faciales ¿realmente debemos preocuparnos?

SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers...

Descripción completa

Detalles Bibliográficos
Autor principal: López Pérez, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AEDV. Published by Elsevier España, S.L.U. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159960/
https://www.ncbi.nlm.nih.gov/pubmed/35659611
http://dx.doi.org/10.1016/j.ad.2022.05.019
_version_ 1784719171731324928
author López Pérez, V.
author_facet López Pérez, V.
author_sort López Pérez, V.
collection PubMed
description SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers, mainly in the face, have also been reported to occur after confirmed SARS-CoV-2 infections and in vaccinated individuals. While delayed inflammatory reactions tend to be self-limiting, they should be diagnosed and treated with corticosteroids, hyaluronidase, and/or antibiotics when necessary. The inflammation is generally not severe, yet these complications are classified as serious adverse events by the US Food and Drug Administration. They appear to be delayed type IV hypersensitivity reactions triggered by the immune system in the presence of SARS-CoV-2 or other viruses, such as those causing influenza, although the underlying mechanisms have not been fully elucidated. Because the longevity of dermal fillers is increasing, while the pandemic continues to evolve and new vaccines are under development, the long-term effects on hyaluronic acid fillers and other bioimplant materials should be studied. Physicians must also be encouraged to report these reactions, however mild, to ensure accurate records.
format Online
Article
Text
id pubmed-9159960
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AEDV. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-91599602022-06-02 COVID y rellenos faciales ¿realmente debemos preocuparnos? López Pérez, V. Actas Dermosifiliogr Revisión SARS-CoV-2 has caused millions of infections and deaths worldwide and case numbers continue to rise. Besides the effect of the virus on key organs — leading to respiratory illness, anosmia, diarrhea, and fever and other complications — delayed inflammatory reactions to hyaluronic acid dermal fillers, mainly in the face, have also been reported to occur after confirmed SARS-CoV-2 infections and in vaccinated individuals. While delayed inflammatory reactions tend to be self-limiting, they should be diagnosed and treated with corticosteroids, hyaluronidase, and/or antibiotics when necessary. The inflammation is generally not severe, yet these complications are classified as serious adverse events by the US Food and Drug Administration. They appear to be delayed type IV hypersensitivity reactions triggered by the immune system in the presence of SARS-CoV-2 or other viruses, such as those causing influenza, although the underlying mechanisms have not been fully elucidated. Because the longevity of dermal fillers is increasing, while the pandemic continues to evolve and new vaccines are under development, the long-term effects on hyaluronic acid fillers and other bioimplant materials should be studied. Physicians must also be encouraged to report these reactions, however mild, to ensure accurate records. AEDV. Published by Elsevier España, S.L.U. 2022-10 2022-06-02 /pmc/articles/PMC9159960/ /pubmed/35659611 http://dx.doi.org/10.1016/j.ad.2022.05.019 Text en © 2022 AEDV. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revisión
López Pérez, V.
COVID y rellenos faciales ¿realmente debemos preocuparnos?
title COVID y rellenos faciales ¿realmente debemos preocuparnos?
title_full COVID y rellenos faciales ¿realmente debemos preocuparnos?
title_fullStr COVID y rellenos faciales ¿realmente debemos preocuparnos?
title_full_unstemmed COVID y rellenos faciales ¿realmente debemos preocuparnos?
title_short COVID y rellenos faciales ¿realmente debemos preocuparnos?
title_sort covid y rellenos faciales ¿realmente debemos preocuparnos?
topic Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159960/
https://www.ncbi.nlm.nih.gov/pubmed/35659611
http://dx.doi.org/10.1016/j.ad.2022.05.019
work_keys_str_mv AT lopezperezv covidyrellenosfacialesrealmentedebemospreocuparnos